Clinic Software← All companies
Celestia Life Sciences
Decoding Complex Chronic Conditions
health AImedtechdigital health
Raised$375.0K
Founded2022
Employees3
LocationBirmingham, AL
About
Celestia Life Science is developing a clinical bioinformatics platform and laboratory for generating a clearer understanding of complex chronic conditions, such as Long COVID, POTS, and endometriosis.
Product
- Value proposition
- Clinical bioinformatics and diagnostics for Long COVID, ME/CFS, POTS, and other complex chronic conditions.
- Target customers
- healthcare providers, clinics, hospitals, payers, researchers
Founders
- Mendel Fishman — CEO
Categories
Products
bioinformatics platformlab tests for complex chronic conditionsdiagnostic tools for patient stratification
Key features
robust, actionable insights to improve clinical decisionsdesigned to fit existing care systemsdevelopment pathways for new treatments using patient databench-to-clinic optimizationinformative biomarkers for screening and treatment response
Technologies
bioinformaticslab testsdiagnosticsdata-driven decision support
Integrations
EHRs / healthcare IT systems (unspecified)
Target conditions
Long COVIDME/CFSPOTSother complex chronic conditions
Care settings
clinicalhospitallabvirtual
Investors
Therapeutics Development Fundgener8tor
News
- Alabama Startups Selected for gBETA Prosper HealthTech Accelerator · 2026-05-05T00:00:00.000Z
- Cellestial Health: Pioneering astrocyte-targeting therapeutics for Parkinson’s and beyond – Cambridge Enterprise · 2025-12-02T09:30:29.000Z
- Cellestial Health Closes Pre-Seed Equity Round – Cellestial Health · 2025-05-08T12:58:48.000Z
- Introducing Cellestial Health: Pioneering novel therapeutics for brain disorders | Zinc · 2024-12-05T09:33:59.000Z
- Cellestial Health officially opens Seed funding round – Cellestial Health · 2025-11-21T17:48:47.000Z
- Cellestial Health announces investment from Zinc VC - News & insight - Cambridge Judge Business School · 2024-12-11T16:08:49.000Z
